Endoplex F Liquid
NDC Package 43857-0417-1
Package Information
Endoplex F (cimicifuga racemosa, fucus vesiculosus, glycyrrhiza glabra, xanthoxylum fraxineum, adrenalinum, cerebrum suis, hypophysis suis, hypothalamus (suis), oophorinum (suis), pineal (suis), thyroidinum (suis), pulsatilla (vulgaris), sepia) liquids is for temporary relief of menstrual pain and cramps, pain immediately prior to menses, and sore tender breasts associated with menstruation. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0417.
Identification & Billing
Clinical Specifications
- BLACK COHOSH 3 [hp_X]/mL
- EPINEPHRINE 8 [hp_X]/mL
- FUCUS VESICULOSUS 3 [hp_X]/mL
- GLYCYRRHIZA GLABRA 3 [hp_X]/mL
- PULSATILLA VULGARIS WHOLE 12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- SUS SCROFA CEREBRUM 8 [hp_X]/mL
- SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL
- SUS SCROFA OVARY 8 [hp_X]/mL
- SUS SCROFA PINEAL GLAND 8 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL
- THYROID 8 [hp_X]/mL
- ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0417 - Endoplex F
- 43857-0417-1 - 30 mL in 1 BOTTLE, DROPPER
- 43857-0417 - Endoplex F
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0417-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Endoplex F, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains black cohosh; epinephrine; fucus vesiculosus; glycyrrhiza glabra; pulsatilla vulgaris whole; sepia officinalis juice; sus scrofa cerebrum; sus scrofa hypothalamus; sus scrofa ovary; sus scrofa pineal gland; sus scrofa pituitary gland, posterior; thyroid; zanthoxylum americanum bark as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on September 29, 2016. The current certification is valid through December 31, 2027.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857041701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.